• Logo
  • SBMUJournals

The Safety and Efficacy of the 1540nm Non-Ablative Fractional XD Probe of Star Lux 500 Device in the Treatment of Striae Alba: Before-After Study

Farhad Malekzad, Safoura Shakoei, Azin Ayatollahi, Somayeh Hejazi




Introduction: Striae distensae (SD) are a frequent skin condition for which treatment remains a challenge. The 1540-nm non-ablative fractional laser (Star Lux 500) has been shown to improve atrophic scars by increasing the amount of dermal collagen. To assess the safety and efficacy of the Star Lux 500 laser in the treatment of mature hypopigmented striae in Persian people (Striae Alba).

Methods: Ten women aged 26–50 years with SD and Fitzpatrick skin types III–V were enrolled in the study. The exclusion criteria were a history of keloids, photosensitivity and collagen, elastin disorders as well as history of other striae treatment within one year. The lesions were treated with non-ablative fractional laser 1540nm, and a total of four treatments were given at 4-week intervals. Clinical standard photographs were taken before each treatment. Also, patients were followed up at 3 months after the last treatment. Clinical improvement was assessed by comparing baseline and post-treatment photographs by two independent blinded physicians using grading scale. Treatment efficacy analysis was performed via the comparison between the images taken before and after each treatment session.

Results: There was a clinically appreciable improvement in striae ranging from 1 to 24%. A significant improvement in striae between the 16-week treatment and the 4-week treatment was identified (P<0.0001). Three months after the final treatment, patients showed noticeable improvement in the striae, compared with baseline (P<0.048). Mild post inflammatory hyperpigmentation was observed in one patient after the 8-week treatment and mild to moderate acne occurred in another patient after 4 weeks of treatment.

Conclusion: Therapy with Star lux 500 laser had clinically and statistically striae improvement with no adverse events. This may be a safe and an effective treatment modality for Striae Alba lesions.


striae; laser; lesion


Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, Geronemus RG. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypo pigmented scars and striae Alba. Arch Dermatol 2004; 140:955-60.

Elsaie ML, Baumann LS, Elsaaiee LT. Striae distensae (stretch marks) and different modalities of therapy: an update. Dermatol Surg 2009; 35:563-73.

Tay YK, Kwok C, Tan E. Non ablative 1,450 nm diode laser treatment of striae distensae. Lasers Surg Med 2006; 38:196–99.

Singh G, Kumar LP. Striae distensae. Indian J Dermatol Venereol Leprol 2005; 71(5):370-2.

Ostovari N, Saadat N, Nasiri S, Moravvej H, Toossi P. The 308-nm excimer laser in the darkening of the white lines of striae alba. J Dermatolog Treat 2010; 21:229-31.

Goldberg DJ, Sarradet D, Hussain M. 308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg 2003; 29:596-8.

Goel A, Krupashankar DS, Aurangabadkar S, Nischal KC, Omprakash HM, Mysore V. Fractional lasers in dermatology--current status and recommendations. Indian J Dermatol Venereol Leprol 2011; 77:369-79.

Taub AF. Fractionated delivery systems for difficult to treat clinical applications: acne scarring, melisma, atrophic scarring, striae distensae, and deep rhytides. J Drugs Dermatol 2007; 6:1120-8.

Suh DH, Chang KY, Son HC, Ryu JH, Lee SJ, Song KY. Radiofrequency and 585-nmpulsed dye laser treatment of striaedistensae: a report of 37Asian patients. Dermatol Surg 2007; 33:29-34.

Kim BJ, Lee DH, Kim MN, Song KY, Cho WI, Lee CK, Kim JY, Kwon OS. Fractional photothermolysis for the treatment of striae distensae in Asian skin. Am J Clin Dermatol 2008; 9:33-7.

Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58:719-37.


Hedelund L, Moreau KE, Beyer DM, Nymann P, Haedersdal M. Fractional nonablative 1,540-nm laser resurfacing of atrophic acne scars. A randomized controlled trial with blinded response evaluation. Lasers Med Sci 2010; 2:749-54.

Sachdeva S. Nonablative fractional laser resurfacing in Asian skin--a review. J Cosmet Dermatol 2010; 9:307-12.

Moravvej H, Barikbin B, Ghavam S A, Karimi S. Nonablative Fractional Laser Resurfacing. Jf Lasers Med Sci 2011; 2:30-5.

Manuskiatti W, Boonthaweeyuwat E, Varothai S. Treatment of striaedistensae with a TriPollar radiofrequency device: A pilot study. J Dermatol Treat 2009; 20:359–64.

You Jin Yang, Ga-Young Lee. Treatment of Striae Distensae with Nonablative Fractional Laser versus Ablative CO2 Fractional Laser: A Randomized Controlled Trial. Ann Dermatol 2011; 23:481–9.

De Angelis F, Kolesnikova L, Renato F, Liguori G. Fractional nonablative 1540-nm laser treatment of striaedistensae in Fitzpatrick skin types II to IV: clinical and histological results. Aesthet Surg J 2011; 31:411-9.

DOI: https://doi.org/10.22037/jlms.v5i4.4152